Qureshi Sabuhi, Das Vinta, Zahra Fatima
Department of Obstetrics and Gynaecology, CSM Medical University, Lucknow, India.
Trop Doct. 2010 Jan;40(1):9-12. doi: 10.1258/td.2009.090085. Epub 2009 Dec 11.
In view of the failure of cytology screening programmes for cervical cancer in developing countries, the World Health Organization suggested unaided visual inspection of the cervix after an application of acetic acid (VIA) and Lugol's iodine (VILI) as alternative screening methods. Our study evaluates the effectiveness of VIA and VILI compared to Pap smear as screening methods for carcinoma of the cervix in a low-resource setting. Three hundred and twenty-eight women were subjected to a Pap smear test, VIA, VILI and colposcopy. The results were as follows: Pap smear test (20.83%, specificity 98.38%), VIA (55.5%, 71.39%) and VILI (86.84%, 48.93%). Although VIA and VILI are less specific in comparison to the Pap smear test, they are more sensitive in detecting pre-invasive lesions. Hence VIA and VILI can be used as cervical cancer screening tools in low-resource settings.
鉴于发展中国家宫颈癌细胞学筛查项目的失败,世界卫生组织建议采用醋酸涂抹后肉眼观察法(VIA)和卢戈氏碘液涂抹后肉眼观察法(VILI)作为替代筛查方法。我们的研究评估了在资源匮乏地区,VIA和VILI与巴氏涂片法相比作为宫颈癌筛查方法的有效性。328名女性接受了巴氏涂片检查、VIA、VILI和阴道镜检查。结果如下:巴氏涂片检查(灵敏度20.83%,特异性98.38%),VIA(灵敏度55.5%,特异性71.39%)和VILI(灵敏度86.84%,特异性48.93%)。虽然与巴氏涂片检查相比,VIA和VILI的特异性较低,但它们在检测癌前病变方面更敏感。因此,VIA和VILI可作为资源匮乏地区的宫颈癌筛查工具。